Tag: RGLS

Stock Earnings

Regulus Therapeutics Inc [RGLS] Chief Executive Officer makes an insider purchase of 14,580 shares worth 17359.0.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Regulus Therapeutics Inc’s latest rating changes from various analysts

In a filing, Regulus Therapeutics Inc revealed its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0

Analysts Viewpoint

Leerink Partners analysts initates an Outperform rating for Regulus Therapeutics Inc (RGLS)

Regulus Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0